ScreenPro FH
Screening Project for Familial Hypercholesterolemia
in Central, Southern and Eastern Europe

New ScreenPro FH Project partnership with FH Europe

ScreenPro FH partners with FH Europe to build stronger advocacy in Central, Eastern and Southern Europe. In the efforts to build a stronger international “one voice” for the Familial Hypercholesterolaemia community, ScreenPro FH is pleased to partner with FH Europe. With this partnership in place ScreenPro FH intends to collaborate with FH Europe and its members to deliver on our shared mission and reach countries with unmet needs.... More

New videos focused on POs

The ScreenPro FH Project together with Czech Patient Organisation Diagnoza FH prepared two new educational videos. The first video is focused on topic: Networking - why to be a part of community.

ScreenPro FH publiaction

"The Impact of the International Cooperation On FH Screening and Treatment: Results from the ScreenPro FH Project" was published in the Current Atherosclerosis Reports in September 2019.

FH and Covid-19: triggering of increased sustained CV risk

Approximately 30 million people worldwide suffer from FH. These patients have an increased risk of atherosclerotic CV disease and its atherothrombotic complications already in middle age. It is likely that COVID-19 further increases their cardiovascular risk, both during infection and after recovery. We advise continued use of treatment for the severe hypercholesterolaemia observed in these patients.